The diagnostic journey of pulmonary arterial hypertension patients: results from a multinational real-world survey.
Mark SmallLoïc PerchenetAlex BennettJörg LinderPublished in: Therapeutic advances in respiratory disease (2024)
Our data suggest that diagnostic delay in PAH results from patient- and physician-related factors, which differ across regions and include lack of awareness of PAH on both sides. Development of better screening strategies may help address this barrier to timely PAH diagnosis.
Keyphrases
- pulmonary arterial hypertension
- end stage renal disease
- pulmonary artery
- pulmonary hypertension
- chronic kidney disease
- emergency department
- polycyclic aromatic hydrocarbons
- newly diagnosed
- ejection fraction
- primary care
- prognostic factors
- case report
- cross sectional
- patient reported outcomes
- electronic health record
- machine learning
- big data